
Making major Alzheimer’s breakthrough news worldwide, clinical trial data reported by The Guardian reveals that an experimental pill called AR1001—which mimics the blood-vessel-relaxing mechanism of Viagra—can slow cognitive decline in Alzheimer’s patients by almost 30%. Functioning as a phosphodiesterase-5 inhibitor, the medication increases blood circulation to the brain to protect vulnerable neural tissue. Medical experts called the results “very promising” as researchers expand Phase 3 clinical trials across 13 countries to confirm its long-term efficacy against dementia.